Dynavax Technologies | DVAX - Pe Prix À Revenus



Pe Changement Date
AbbVie 24.03 86.23 2025-12
Adma Biologics 29.73 12.48 2025-12
Amgen 25.31 15.82 2025-12
AstraZeneca 27.29 5.8 2025-12
Biogen 14.02 4.63 2025-12
BioMarin Pharmaceutical 19.24 0.21 2025-12
Bristol-Myers Squibb 9.28 1.04 2025-12
Gilead Sciences 15.63 0.08 2025-12
Glaxosmithkline 11.66 0.28 2025-12
Merck 13.92 5.08 2025-12
Neurocrine Biosciences 835.47 802.2 2025-12
Novartis 17.85 2.11 2025-12
Pfizer 14.48 5.18 2025-12
Regeneron Pharmaceuticals 18.11 2.91 2025-12
Roche Holding 16.09 3.51 2025-12
Sarepta Therapeutics 27.27 0 2025-09
TG Therapeutics 10.76 2.32 2025-12
Vertex Pharmaceuticals 26.15 2.22 2025-12